Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
121,543,157
-
Total 13F shares
-
14,171,891
-
Share change
-
+14,171,891
-
Total reported value
-
$106,290,000
-
Price per share
-
$7.50
-
Number of holders
-
18
-
Value change
-
+$106,290,000
-
Number of buys
-
18
Institutional Holders of Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI) as of Q2 2019
As of 30 Jun 2019 Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI) had 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 14,171,891 shares of stock of the company.
Largest 10 holders included TPG Group Holdings (SBS) Advisors, Inc., NEA Management Company, LLC, Omega Fund Management, LLC, FMR LLC, FRANKLIN RESOURCES INC, Schonfeld Strategic Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Alyeska Investment Group, L.P., and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 18 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.